TY - JOUR
T1 - Satisfaction with work-life balance and the career and retirement plans of US oncologists
AU - Shanafelt, Tait D.
AU - Raymond, Marilyn
AU - Kosty, Michael
AU - Satele, Daniel
AU - Horn, Leora
AU - Pippen, John
AU - Chu, Quyen
AU - Chew, Helen
AU - Clark, William Benton
AU - Hanley, Amy E.
AU - Sloan, Jeff
AU - Gradishar, William J.
PY - 2014/4/10
Y1 - 2014/4/10
N2 - Purpose: To evaluate satisfaction with work-life balance (WLB) and career plans of US oncologists. Methods: The American Society of Clinical Oncology conducted a survey of US oncologists evaluating satisfaction with WLB and career plans between October 2012 and March 2013. The sample included equal numbers of men and women from all career stages. Results: Of 2,998 oncologists contacted, 1,490 (49.7%) returned surveys. From 1,117 oncologists (37.3% of overall sample) completing full-length surveys, we evaluated satisfaction with WLB and career plans among the 1,058 who were not yet retired. The proportion of oncologists satisfied with WLB (n = 345; 33.4%) ranked lower than that reported for all other medical specialties in a recent national study. Regarding career plans, 270 oncologists (26.5%) reported a moderate or higher likelihood of reducing their clinical work hours in the next 12 months, 351 (34.3%) indicated a moderate or higher likelihood of leaving their current position within 24 months, and 273 (28.5%) planned to retire before 65 years of age. Multivariable analyses found women oncologists (odds ratio [OR], 0.458; P < .001) and those who devoted greater time to patient care (OR for each additional hour, 0.977; P < .001) were less likely to be satisfied with WLB. Satisfaction with WLB and burnout were the strongest predictors of intent to reduce clinical work hours and leave current position on multivariable analysis. Conclusion: Satisfaction with WLB among US oncologists seems lower than for other medical specialties. Dissatisfaction with WLB shows a strong relationship with plans to reduce hours and leave current practice. Given the pending US oncologist shortage, additional studies exploring interactions among WLB, burnout, and career satisfaction and their impact on career and retirement plans are warranted.
AB - Purpose: To evaluate satisfaction with work-life balance (WLB) and career plans of US oncologists. Methods: The American Society of Clinical Oncology conducted a survey of US oncologists evaluating satisfaction with WLB and career plans between October 2012 and March 2013. The sample included equal numbers of men and women from all career stages. Results: Of 2,998 oncologists contacted, 1,490 (49.7%) returned surveys. From 1,117 oncologists (37.3% of overall sample) completing full-length surveys, we evaluated satisfaction with WLB and career plans among the 1,058 who were not yet retired. The proportion of oncologists satisfied with WLB (n = 345; 33.4%) ranked lower than that reported for all other medical specialties in a recent national study. Regarding career plans, 270 oncologists (26.5%) reported a moderate or higher likelihood of reducing their clinical work hours in the next 12 months, 351 (34.3%) indicated a moderate or higher likelihood of leaving their current position within 24 months, and 273 (28.5%) planned to retire before 65 years of age. Multivariable analyses found women oncologists (odds ratio [OR], 0.458; P < .001) and those who devoted greater time to patient care (OR for each additional hour, 0.977; P < .001) were less likely to be satisfied with WLB. Satisfaction with WLB and burnout were the strongest predictors of intent to reduce clinical work hours and leave current position on multivariable analysis. Conclusion: Satisfaction with WLB among US oncologists seems lower than for other medical specialties. Dissatisfaction with WLB shows a strong relationship with plans to reduce hours and leave current practice. Given the pending US oncologist shortage, additional studies exploring interactions among WLB, burnout, and career satisfaction and their impact on career and retirement plans are warranted.
UR - http://www.scopus.com/inward/record.url?scp=84901841885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901841885&partnerID=8YFLogxK
U2 - 10.1200/JCO.2013.53.4560
DO - 10.1200/JCO.2013.53.4560
M3 - Article
C2 - 24616305
AN - SCOPUS:84901841885
SN - 0732-183X
VL - 32
SP - 1127
EP - 1135
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 11
ER -